n n n ‘.concat(e.i18n.t(“search.voice.recognition_retry”),’n
The company’s platform expansion transforms the value of US healthcare data by harnessing real-time, regulatory-grade data in any therapeutic area to efficiently understand the complex medical histories of patients and drive research through detailed, longitudinal datasets.
OAKLAND, Calif., Jan. 31, 2024 /PRNewswire/ — xCures, a trailblazer in healthcare technology, announced today the expansion of its AI-assisted medical data platform to support real-time, regulatory-grade data in any therapeutic area. Originally designed as a tool focused specifically on cancer, the company’s platform expansion now serves as a comprehensive tool to collect and understand medical records for any US patient with any condition.
Leveraging AI/ML technology, the xCures platform collects records, extracts and aggregates data, aggregating and structuring clinical, genomic, and imaging data from a variety of sources, into a searchable virtual registry. This solution can help any user locate or temporarily locate compare key clinical data about a patient for care-related activities. This built-in technique transforms the way healthcare professionals and researchers can perceive complex patient and cohort characteristics.
Cures makes this generation available through on-platform software licenses and direct API connections built into existing healthcare workflow control platforms. The formula provides a patient-centered longitudinal perspective, which is imperative for informed decision-making.
This progression marks another step forward that will especially benefit those making knowledge-based health care decisions. Since the data collected may also be anonymized, it may be available for secondary searches; xCures provides the ultimate comprehensive patient-centered longitudinal knowledge in the form of real-world, anonymous knowledge sets that involve a comprehensive setup across providers and places of care.
“The extension of our AI platform beyond oncology marks a vital milestone in our healthcare knowledge pricing project,” said Mika Newton, CEO of xCures. “We offer access to a software platform that generates accurate, real-world knowledge at the individual and cohort point for all diseases, driving innovative studies in many spaces and gaining direct benefits for patients. “
With its ability to aggregate and interpret diverse medical records temporally and accurately, the xCures platform is a game-changer for anyone who wants to access and interpret retrospective and prospective or real-world physical care data. It facilitates in-depth understanding of medical patterns and situations and improves the scope of clinical trials and disease studies. Making this generation available across the fitness ecosystem as a platform solution transforms the ability to leverage U. S. fitness data into the U. S. and Canada. U. S.
For more information, visit https://xcures.com/
ABOUT XCURES
Launched in 2018, xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Through a variety of equipment and knowledge products, xCures provides clinically actionable, real-time insights that facilitate clinical studies and care for patients, providers, and partners. For more information, tap info@xcures. com or visit http://www. xcures. com.
See the content to download the multimedia: https://www. prnewswire. com/news-releases/xcures-unveils-expanded-ai-health-data-platform-now-supporting-all-therapeutic-areas-and-is- available -as-saas-302049410. html
SOURCE xCures